Product Program year 2021 Source: CMS Open Payments

HeartMate 3 Left Ventricular Assist Device

Device Heart failure

PDI 813024013297

Open in the dashboard

General payments

$9,235

134 payments

Research payments

$0

0 payments

Through program year 2021, $9,235 in general payments and $0 in research payments were reported against HeartMate 3 Left Ventricular Assist Device (Heart failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $9,235 134

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $9,235 134 payments
Top recipients General payments · program year 2021
  1. Andrew Pollard Cardiovascular Disease · Cincinnati, OH $334 4% · 2 payments
  2. Rogin Subedi Cardiovascular Disease · Ocean Springs, MS $287 3% · 2 payments
  3. Paurush Ambesh Cardiovascular Disease · Albany, NY $239 3% · 1 payment
  4. Andrew Mathew Clinical Cardiac Electrophysiology · Chambersburg, PA $238 3% · 1 payment
  5. Jarred Sargeant Interventional Cardiology · Sumter, SC $227 2% · 1 payment

The top 5 of 89 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $2,459 33% · 21 practitioners
  2. Interventional Cardiology Internal Medicine $2,001 27% · 18 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $1,121 15% · 7 practitioners
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $602 8% · 5 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $479 6% · 5 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Ohio $1,427 15% · 13 recipients
  2. New York $1,354 15% · 11 recipients
  3. California $1,230 13% · 9 recipients
  4. Florida $888 10% · 9 recipients
  5. Texas $840 9% · 15 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

134 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record